MNX1 Gene Currarino Syndrome NGS Genetic DNA Test
Introduction
The MNX1 Gene Currarino Syndrome NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the MNX1 gene, which are responsible for Currarino syndrome. This genetic disorder is characterized by a triad of spinal malformations, including the presence of a sacral dimple, a defect in the spinal cord, and anal atresia. Early diagnosis through genetic testing is crucial for effective management and treatment of the associated complications.
What the Test Measures
This test specifically measures mutations in the MNX1 gene using advanced Next Generation Sequencing (NGS) technology. By analyzing the genetic material, healthcare providers can confirm the diagnosis of Currarino syndrome and assess the risk of transmission to future generations.
Who Should Consider This Test
Individuals with a family history of Currarino syndrome, those exhibiting symptoms such as spinal anomalies, or patients with related dysmorphology should consider this test. Genetic counseling is recommended to understand the implications of the results fully.
Benefits of Taking the Test
- Accurate diagnosis of Currarino syndrome.
- Informed family planning decisions based on genetic risk assessment.
- Guidance for managing associated health complications.
- Access to support resources for affected families.
Understanding Your Results
Results from the MNX1 Gene Currarino Syndrome NGS Genetic DNA Test will be provided with a detailed interpretation. A genetic counselor will assist in understanding the implications of the results, including potential health risks and family planning options.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Book the Test
To book the MNX1 Gene Currarino Syndrome NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your appointment and answering any questions you may have.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for the test can be blood, extracted DNA, or even a drop of blood on an FTA card. Prior to testing, a clinical history of the patient and a genetic counseling session to create a pedigree chart of affected family members is essential.
